Breakthrough Cancer Treatments Raise Difficult Questions

Health Aff (Millwood). 2017 Oct 1;36(10):1698-1700. doi: 10.1377/hlthaff.2017.1032.

¹ Karen J. Maschke (maschkek@thehastingscenter.org) is a research scholar at the Hastings Center, a nonprofit bioethics research institute, in Garrison, New York.
² Michael K. Gusmano is a research scholar at the Hastings Center and an associate professor of health policy at Rutgers University, in New Brunswick, New Jersey.
³ Mildred Z. Solomon is president of the Hastings Center and a professor in the Department of Anaesthesia at Harvard Medical School, in Boston, Massachusetts.

Abstract

The approval of a first-of-its kind cancer therapy creates new challenges related to safety, access, and costs.

Keywords: Access To Care; Ethical Issues; Health Spending; Insurance Coverage < Insurance; cancer treatment.

Project HOPE—The People-to-People Health Foundation, Inc.